Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : EntreMed (ENMD) -- Ignore unavailable to you. Want to Upgrade?

To: LTK007 who wrote (1538)	2/11/1999 9:09:00 PM
From: Anthony@Pacific	Read Replies (2) \| Respond to of 2135

WE know that and thats why you need to refer to the SECfilings to see who is actually going to benefit and when..ENMD is not the stock of choice..but hey people bought VERI instead of VERT and thought they had something..

To: LTK007 who wrote (1538)	2/11/1999 9:15:00 PM
From: Pluvia	Read Replies (2) \| Respond to of 2135

<<<This is BIG NEWS for cancer(as a great hope,at least) and for Folkman--but the reafirmation of Folkmans work occurred by NCI scientist working in Folkman's labs at the Childrens Cancer Hospital and NOT at ENMD.>>> Respectfully, I must say I think what you say is emotional and... For lack of a better description, BS. You own a for profit stock, not a "wanna do good for mankind" donation. As such, the REALLY BIG news came from BMY - and it went like this: "We at BMY don't want to waste another cent on ENMD's volatile drug because we don't think it is commercially viable." Take off those rosey "make peace not war glasses" and wake up to the reality that this is a company that needs to earn money. Folkman's "giant" efforts as you say, mean squat to the shareholders if he can't make money doing it. Cheers Steve